Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Kansas?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Kansas resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from a Kansas-licensed provider, including by telemedicine under the Kansas Telemedicine Act (K.S.A. 40-2,210 through 40-2,216), which says telemedicine may be used to establish a valid provider-patient relationship and applies in-person standards of practice and prescribing law. Compounded peptides are available when eligible under federal 503A rules and dispensed by a Kansas pharmacy or a pharmacy registered as a nonresident pharmacy under K.S.A. 65-1657, which bars unregistered out-of-state pharmacies from shipping prescription drugs to Kansas patients or prescribers' offices.

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear; a questionnaire alone is not enough
Compounded GLP-1
Limited

Can a Kansas resident get peptides by telehealth?

The Kansas Telemedicine Act (2018) defines telemedicine as the delivery of healthcare services while the patient and provider are at different sites, and says it shall be provided by means of real-time two-way interactive audio, visual, or audio-visual communications, including the application of secure video conferencing or store-and-forward technology to provide or support healthcare delivery (K.S.A. 40-2,211(a)(5)). A physician-patient exchange that consists solely of e-mail or fax is not telemedicine. K.S.A. 40-2,212 states that telemedicine may be used to establish a valid provider-patient relationship, that in-person standards of practice and conduct apply, that the provider must give guidance on follow-up care, and that with patient consent the provider must send a report to the patient's primary care or treating physician within three business days. K.S.A. 40-2,214 directed the State Board of Healing Arts to adopt rules on prescribing by telemedicine, and K.A.R. 100-77-3 says the same laws and regulations that apply to in-person prescribing, including for controlled substances, apply to prescribing by telemedicine. The Pharmacy Act adds that a prescription issued solely on the basis of an internet-based questionnaire or consultation without an appropriate prescriber-patient relationship is not a valid prescription order (K.S.A. 65-1626(yyy)). This record leaves asynchronous prescribing unknown because the law is ambiguous: the definition requires real-time two-way communication yet also names store-and-forward technology, and no statute or Board regulation says whether a purely asynchronous first encounter counts as telemedicine. [2] [3] [7] [8] [9] [10]

How does the Kansas pharmacy board treat compounding?

Compounding regulator for Kansas
BoardKansas State Board of Pharmacy
Eligible substancesFollows the federal 503A framework

The Kansas State Board of Pharmacy regulates pharmacies under the Kansas Pharmacy Act (K.S.A. 65-1625 and following) and Board regulations in K.A.R. Article 68. Kansas has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). K.S.A. 65-1657 bars any nonresident pharmacy from shipping, mailing, or delivering prescription drugs or devices to a patient, a patient's agent, or a prescriber's office in Kansas unless it holds an annual Kansas nonresident pharmacy registration, and it prohibits unregistered pharmacies from advertising to Kansas residents. Covering shipments to prescribers' offices matters for clinics that order compounded peptides for in-office administration. Compounding standards are in K.A.R. Article 13 of the Board's regulations: 68-13-2 (definitions), 68-13-3 (nonsterile preparations), and 68-13-4 (sterile preparations), and 68-13-4 bars compounding a sterile preparation that is essentially a copy of a commercially available drug unless the prescriber documents a clinically significant difference for the individual patient or the drug is on the federal shortage list. House Bill 2068 (2026) adopts USP chapters 795, 797, and 825 under the Kansas Pharmacy Act effective July 1, 2027, and the Board is drafting matching amendments to Article 13. [1] [4] [5] [6] [11] [12]

Can you get compounded GLP-1s in Kansas?

Regulatory: Compounded GLP-1 limited

Kansas patients using telehealth GLP-1 programs should confirm the prescriber holds a Kansas license and that the dispensing pharmacy has a Kansas nonresident pharmacy registration under K.S.A. 65-1657. The Kansas Board of Pharmacy's statement on compounding and dispensing GLP-1 and GIP receptor agonists (last updated August 26, 2026) says semaglutide and tirzepatide are no longer in shortage, that no salt form of either may be used in a compounded drug, and that even when compounding is otherwise allowed, a non-pharmaceutical grade bulk substance or one not made in an FDA-registered establishment is prohibited. It also says pre-printed or check-box prescriptions may not document the patient-specific need that copies of approved drugs require, and that retatrutide and cagrilintide cannot be used to compound under federal law. [6] [11] [15] [16]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Kansas?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Kansas

What you'll actually find in Kansas, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [20] [21] [22]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [23]

What Kansas has done

PeptideAgent has not found a board or legislative action on peptides in Kansas.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [25] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [26] [27] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Kansas. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. State law says an online questionnaire alone is not enough. [2] [3] [7] [8] [9] [10] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Kansas State Board of Pharmacy; its license search: FDA BeSafeRx: state board of pharmacy license lookups. [24]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [23]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [13] [28] [29]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [24] [30] [31]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [22] [31] [32]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [23] [33] [34] [35] [36] [37]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [23]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [24]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [22]
  • Pharmacy: Is this made for me on a prescription written in my name? [32]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [22] [31]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [22]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Kansas?

K.S.A. 65-1657 bars unregistered nonresident pharmacies from shipping prescription drugs into Kansas and from advertising to Kansas residents. The Kansas Board of Pharmacy's GLP-1 statement adds that compounding pharmacies must use pharmaceutical-grade active ingredients, not research use, investigational, food, or supplement grade, with a certificate of analysis naming the original manufacturer, and that a pharmacist may not dispense a product compounded in a non-compliant manner. [6] [11] [17]

Peptide-specific notes for Kansas

Peptide-specific notes for Kansas
PeptideNote
SemaglutideAvailable branded by prescription, including by telemedicine under the Kansas Telemedicine Act, which requires a report to your primary care physician within three business days when you consent. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [8] [15]

Frequently asked questions

Can a telehealth provider start me on a GLP-1 in Kansas without an office visit?

Yes, if the provider is licensed in Kansas and meets in-person standards of practice. K.S.A. 40-2,212 says telemedicine may be used to establish a valid provider-patient relationship, and prescribing by telemedicine follows the same laws as in-person prescribing. Kansas law does not settle whether a visit with no live contact is enough: the telemedicine definition requires real-time two-way communication yet also names store-and-forward technology. A prescription based only on an internet questionnaire, without an appropriate prescriber-patient relationship, is not valid under K.S.A. 65-1626(yyy). [7] [8] [9] [10]

Will my regular doctor be told about a telehealth prescription in Kansas?

If you consent and have a primary care or treating physician, K.S.A. 40-2,212 requires the telemedicine provider to send that physician a report of the treatment within three business days. [8]

What does an out-of-state pharmacy need to ship compounded peptides to Kansas?

A Kansas nonresident pharmacy registration under K.S.A. 65-1657, renewed annually. The law covers shipments to patients, their agents, and prescribers' offices, and unregistered pharmacies may not advertise to Kansas residents. [11]

Can a Kansas pharmacy compound BPC-157?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Kansas has no separate state bulks list, so peptide eligibility follows the federal 503A framework. [13] [14] [18] [19]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Kansas State Board of Pharmacy
  2. [2]Kansas State Board of Healing Arts
  3. [3]K.A.R. 100-77-3, Prescribing drugs by means of telemedicine (Kansas Secretary of State)
  4. [4]K.A.R. Article 68-13, State Board of Pharmacy regulations (68-13-2 definitions, 68-13-3 nonsterile, 68-13-4 sterile preparations)
  5. [5]Kansas Board of Pharmacy: Compounding compliance (House Bill 2068 adoption of USP 795, 797, and 825)
  6. [6]Kansas Board of Pharmacy: Statement on compounding and dispensing of compounded GLP-1 and GIP receptor agonists (updated August 26, 2026)
  7. [7]K.S.A. 40-2,211, Kansas Telemedicine Act definitions
  8. [8]K.S.A. 40-2,212, Telemedicine confidentiality, provider-patient relationship, and standards of practice
  9. [9]K.S.A. 40-2,214, Prescribing of drugs via telemedicine (rulemaking)
  10. [10]K.S.A. 65-1626, Pharmacy Act definitions (valid prescription order)

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Kansas?. https://peptideagent.ai/legal/kansas
HTML link
<a href="https://peptideagent.ai/legal/kansas">Are peptides legal in Kansas?</a>, PeptideAgent, updated October 28, 2026.